South Korean scientists have developed a method using mussel adhesive protein to connect severed nerve ends without the need to use suture threads.
A joint research team from Pohang University of Science and Technology, Ewha Woman's University, and the Catholic University of Korea Seoul St. Mary’s Hospital announced that it had developed a hydrogel adhesive for medical use based on mussel adhesive protein.
Nerves are one of the more difficult tissues to replicate. As a result, when they are cut, the only option to rejoin them is to carefully sew them together with suture threads.
This approach, however, necessitates a high level of medical expertise and takes a long time. Furthermore, there is a possibility that the secondary injury induced by suture thread penetration will impede nerve cell proliferation.
The researchers aimed to address these issues by transforming mussel adhesive protein into a jelly-like photo-crosslinking hydrogel adhesive.
The protein secreted by mussels to adhere to the moist surfaces of solid rocks is known as mussel adhesive protein.
When not exposed to light, this adhesive lives as a liquid. When exposed to visible light, it rapidly transforms into a hydrogel with sticky properties.
The use of this glue to connect severed nerve segments helps to avoid further injury and minimize immunological inflammation.


Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data
Ancient Mars may have had a carbon cycle − a new study suggests the red planet may have once been warmer, wetter and more favorable for life
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
European Stocks Rise as Markets Await Key U.S. Inflation Data
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Citi Sets Bullish 2026 Target for STOXX 600 as Fiscal Support and Monetary Easing Boost Outlook
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Neuralink Expands Brain Implant Trials with 12 Global Patients 



